Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Peters-Golden

Showing results (21-30 of 183) with videos related to

Pageof 19
Sort By:
Pulmonary Circulation|April 8, 2020
A new treatment for severe pulmonary arterial hypertension based on an old idea: inhibition of 5-lipoxygenaseNorbert F Voelkel, Marc Peters-Golden
American Journal of Respiratory and Critical Care Medicine|July 6, 2010
Prostaglandin E2's new trick: "decider" of differential alveolar cell life and deathJeffrey C Horowitz, Marc Peters-Golden
Expert Review of Clinical Immunology|May 19, 2010
Opposing roles of leukotrienes and prostaglandins in fibrotic lung diseaseBethany B Moore, Marc Peters-Golden
American Journal of Respiratory and Critical Care Medicine|June 28, 2022
From Biomarker to Mechanism? F2-isoprostanes in Pulmonary FibrosisThomas H Thatcher, Marc Peters-Golden
The Journal of Allergy and Clinical Immunology|January 18, 2003
Cysteinyl leukotriene interactions with other mediators and with glucocorticosteroids during airway inflammationMarc Peters-Golden, Anthony P Sampson
Digestive Diseases and Sciences|April 24, 2015
Prostaglandin E₂ and polyenylphosphatidylcholine: stiff competition for the fibrotic complications of inflammatory bowel disease?Steven K Huang, Marc Peters-Golden
Chest|June 25, 2008
Eicosanoid lipid mediators in fibrotic lung diseases: ready for prime time?Steven K Huang, Marc Peters-Golden
Thescientificworldjournal|September 4, 2007
Activation and regulation of cellular eicosanoid biosynthesisThomas G Brock, Marc Peters-Golden
Trends in Molecular Medicine|September 25, 2018
Microenvironmental Influences on Extracellular Vesicle-Mediated Communication in the LungMikel D Haggadone, Marc Peters-Golden
European Respiratory Review : an Official Journal of the European Respiratory Society|February 18, 2026
Mechanistic basis for the antifibrotic actions of cAMP-based therapiesMarc Peters-Golden, Sean M Fortier
Pageof 19

Showing results (21-30 of 183) with videos related to

Sort By:
Pageof 19
Pulmonary Circulation|April 8, 2020
A new treatment for severe pulmonary arterial hypertension based on an old idea: inhibition of 5-lipoxygenaseNorbert F Voelkel, Marc Peters-Golden
American Journal of Respiratory and Critical Care Medicine|July 6, 2010
Prostaglandin E2's new trick: "decider" of differential alveolar cell life and deathJeffrey C Horowitz, Marc Peters-Golden
Expert Review of Clinical Immunology|May 19, 2010
Opposing roles of leukotrienes and prostaglandins in fibrotic lung diseaseBethany B Moore, Marc Peters-Golden
American Journal of Respiratory and Critical Care Medicine|June 28, 2022
From Biomarker to Mechanism? F2-isoprostanes in Pulmonary FibrosisThomas H Thatcher, Marc Peters-Golden
The Journal of Allergy and Clinical Immunology|January 18, 2003
Cysteinyl leukotriene interactions with other mediators and with glucocorticosteroids during airway inflammationMarc Peters-Golden, Anthony P Sampson
Digestive Diseases and Sciences|April 24, 2015
Prostaglandin E₂ and polyenylphosphatidylcholine: stiff competition for the fibrotic complications of inflammatory bowel disease?Steven K Huang, Marc Peters-Golden
Chest|June 25, 2008
Eicosanoid lipid mediators in fibrotic lung diseases: ready for prime time?Steven K Huang, Marc Peters-Golden
Thescientificworldjournal|September 4, 2007
Activation and regulation of cellular eicosanoid biosynthesisThomas G Brock, Marc Peters-Golden
Trends in Molecular Medicine|September 25, 2018
Microenvironmental Influences on Extracellular Vesicle-Mediated Communication in the LungMikel D Haggadone, Marc Peters-Golden
European Respiratory Review : an Official Journal of the European Respiratory Society|February 18, 2026
Mechanistic basis for the antifibrotic actions of cAMP-based therapiesMarc Peters-Golden, Sean M Fortier
Pageof 19